IA
EBS icon

IFP Advisors’s Emergent Biosolutions EBS Stock Holding History

IFP Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.51K Buy
658
+521
+380% +$4.36K ﹤0.01% 3725
2026
Q1 		$1.14K Buy
137
+87
+174% +$901 ﹤0.01% 4168
2025
Q4 		$618 Buy
50
+2
+4% +$21 ﹤0.01% 4225
2025
Q3 		$423 Buy
+48
New +$373 ﹤0.01% 4226
2023
Q1 		– Sell
-33
Closed -$9K – 3655
2022
Q4 		$9K Sell
33
-175
-84% -$2.71K ﹤0.01% 3440
2022
Q3 		$19K Sell
208
-64
-24% -$1.78K ﹤0.01% 3120
2022
Q2 		$22K Hold
272
– – ﹤0.01% 2748
2022
Q1 		$22K Buy
272
+257
+1,713% +$11.3K ﹤0.01% 2748
2021
Q4 		$1K Hold
15
– – ﹤0.01% 2984
2021
Q3 		$1K Sell
15
-271
-95% -$16.4K ﹤0.01% 3011
2021
Q2 		$19K Buy
286
+137
+92% +$8.8K ﹤0.01% 1951
2021
Q1 		$13K Sell
149
-232
-61% -$23.8K ﹤0.01% 2020
2020
Q4 		$34K Buy
381
+85
+29% +$7.8K ﹤0.01% 1587
2020
Q3 		$31K Buy
296
+254
+605% +$27.4K ﹤0.01% 1458
2020
Q2 		$3K Hold
42
– – ﹤0.01% 2252
2020
Q1 		$3K Sell
42
-10
-19% -$576 ﹤0.01% 2238
2019
Q4 		$3K Hold
52
– – ﹤0.01% 2364
2019
Q3 		$3K Buy
+52
New +$2.42K ﹤0.01% 2526
2019
Q1 		– Sell
-205
Closed -$12K – 2622
2018
Q4 		$12K Sell
205
-2
-1% -$129 ﹤0.01% 2400
2018
Q3 		$14K Buy
207
+69
+50% +$4.03K ﹤0.01% 2650
2018
Q2 		$7K Buy
138
+107
+345% +$5.58K ﹤0.01% 3084
2018
Q1 		$1K Hold
31
– – ﹤0.01% 3619
2017
Q4 		$1K Hold
31
– – ﹤0.01% 3670
2017
Q3 		$1K Hold
31
– – ﹤0.01% 3883
2017
Q2 		$1K Hold
31
– – ﹤0.01% 3864
2017
Q1 		$1K Hold
31
– – ﹤0.01% 3783
2016
Q4 		$1K Hold
31
– – ﹤0.01% 3764
2016
Q3 		$1K Sell
31
-309
-91% -$8.98K ﹤0.01% 3704
2016
Q2 		$10K Buy
+340
New +$13.3K ﹤0.01% 2733
2016
Q1 		– Sell
-519
Closed -$21K – 2624
2015
Q4 		$21K Buy
+519
New +$18.1K ﹤0.01% 2131

Other funds holding EBS

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
BWM
Baron Wealth Management Troy, Michigan $386M AUM 30.18% 1-Year Est. Return
HA
Herold Advisors New York $506M AUM 26.75% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MFT
Moisand Fitzgerald Tamayo Orlando, Florida $1.02B AUM 21.26% 1-Year Est. Return
TCM
Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

IFP Advisors's EBS Position: Q2 2026 in Review

IFP Advisors increased its Emergent Biosolutions (EBS) stake by 380% in Q2 2026, buying an estimated $4.36K and bringing the position to 658 shares worth $5.51K. The position accounts for ﹤0.01% of the portfolio, ranked #3725.

IFP Advisors first reported a position in EBS in Q4 2015 and has held it in 30 quarters since. The position peaked at $34K in Q4 2020. 20 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • IFP Advisors held 658 shares of Emergent Biosolutions worth $5.51K as of Q2 2026.
  • IFP Advisors bought 521 Emergent Biosolutions shares in Q2 2026, an estimated $4.36K.
  • Emergent Biosolutions made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3725 holding.
  • IFP Advisors first reported a position in Emergent Biosolutions in Q4 2015 and has held it in 30 quarters since.
  • IFP Advisors's Emergent Biosolutions position peaked at $34K in Q4 2020.
  • 20 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.